NW006-296, a novel ROR1 targeting ADC, demonstrates compelling anti-tumor efficacy in preclinical studies.
霁月光风
1小时前
14
10
已关闭
DOI:
文献链接:
其他信息:
Z Gou, L Zhou, L Liu, Z Zhang, G Liu, Y Wu, D Mi…
Cancer …, 2026
aacrjournals.org
23 天前 - … affinity to human ROR1 (KD=3.9 nM), strong binding to ROR1-… ROR1-expressing
cells. Conjugation to the payload did not compromise binding of the antibody to human ROR1. …

